Stay updated on Dupilumab in AFRS Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in AFRS Clinical Trial page.

Latest updates to the Dupilumab in AFRS Clinical Trial page
- Check4 days agoChange DetectedThe page shows a new revision tag, updating from v3.6.3 to v3.6.4, indicating a small platform or documentation update rather than a change to the study details.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThere are no text changes reported for the page. The content remains unchanged.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision: v3.6.3 was added, replacing v3.6.2 in the page footer to reflect a small update to the study documentation.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, representing a minor release of the page. There are no visible content changes to the AFRS study details.SummaryDifference0.0%

- Check47 days agoChange DetectedThe study record now shows recruitment has ended, and new sections such as How to Read a Study Record, Common Questions, and How to Join a Study were added. The label for Intervention/Treatment was updated from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision badge reflects v3.6.0.SummaryDifference0.3%

- Check54 days agoChange DetectedThe revision tag updated from v3.5.4 to v3.5.5, signaling a new version of the record. This reflects a minor update to the content or metadata associated with the entry.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in AFRS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in AFRS Clinical Trial page.